What lies above and beyond the concept of "sympathetically maintained pain"?

Protein kinase G signaling pathway is involved in sympathetically maintained pain by modulating ATP-sensitive potassium channels

BACKGROUND

Sympathetically maintained pain (SMP) involves an increased excitability of dorsal root ganglion (DRG) neurons to sympathetic nerve stimulation and circulating norepinephrine. The current treatment of SMP has limited efficacy, and hence more mechanistic insights into this intractable pain condition are urgently needed.

METHODS

A caudal trunk transection (CTT) model of neuropathic pain was established in mice.Immunofluorescence staining, small interfering RNA, pharmacological and electrophysiological studies were conducted to test the hypothesis that norepinephrine increases the excitability of small-diameter DRG neurons from CTT mice through the activation of cyclic guanosine monophosphate-protein kinase G (cGMP-PKG) signaling pathway.

RESULTS

Behavior study showed that CTT mice developed mechanical and heat hypersensitivities, which were attenuated by intraperitoneal injection of guanethidine. CTT mice also showed an abnormal sprouting of tyrosine hydroxylase-positive nerve fibers in DRG, and an increased excitability of small-diameter DRG neurons to norepinephrine, suggesting that CTT is a useful model to study SMP. Importantly, inhibiting cGMP-PKG pathway with small interfering RNA and KT5823 attenuated the increased sympathetic sensitivity in CTT mice. In contrast, cGMP activators (Sp-cGMP, 8-Br-cGMP) further increased sympathetic sensitivity. Furthermore, phosphorylation of ATP-sensitive potassium channel, which is a downstream target of PKG, may contribute to the adrenergic modulation of DRG neuron excitability.

CONCLUSIONS

Our findings suggest an important role of cGMP-PKG signaling pathway in the increased excitability of small-diameter DRG neurons to norepinephrine after CTT, which involves an inhibition of the ATP-sensitive potassium currents through PKG-induced phosphorylation. Accordingly, drugs targeting this pathway may help to treat SMP.

Effects of deep and superficial experimentally induced acute pain on muscle sympathetic nerve activity in human subjects

Human studies conducted more than half a century ago have suggested that superficial pain induces excitatory effects on the sympathetic nervous system, resulting in increases in blood pressure (BP) and heart rate (HR), whereas deep pain is believed to cause vasodepression. To date, no studies have addressed whether deep or superficial pain produces such differential effects on muscle sympathetic nerve activity (MSNA). Using microneurography we recorded spontaneous MSNA from the common peroneal nerve in 13 awake subjects. Continuous blood pressure was recorded by radial arterial tonometry. Deep pain was induced by intramuscular injection of 0.5 ml hypertonic saline (5%) into the tibialis anterior muscle, superficial pain by subcutaneous injection of 0.2 ml hypertonic saline into the overlying skin. Muscle pain, with a mean rating of 4.9 +/- 0.8 (S.E.M.) on a 0-10 visual analog scale (VAS) and lasting on average 358 +/- 32 s, caused significant increases in MSNA (43.9 +/- 10.0%), BP (5.4 +/- 1.1%) and HR (7.0 +/- 2.0%) - not the expected decreases. Skin pain, rated at 4.9 +/- 0.6 and lasting 464 +/- 54 s, also caused significant increases in MSNA (38.2 +/- 12.8%), BP (5.1 +/- 2.1%) and HR (5.6 +/- 2.0%). The high-frequency (HF) to low-frequency (LF) ratio of heart rate variability (HRV) increased from 1.54 +/- 0.25 to 2.90 +/- 0.45 for muscle pain and 2.80 +/- 0.52 for skin pain. Despite the different qualities of deep (dull and diffuse) and superficial (burning and well-localized) pain, we conclude that pain originating in muscle and skin does not exert a differential effect on muscle sympathetic nerve activity, both causing an increase in MSNA and an increase in the LF:HF ratio of HRV. Whether this holds true for longer lasting experimental pain remains to be seen.

Acute response to intracisternal bupivacaine in patients with refractory pain of the head and neck

Continuous intracisternal infusion of bupivacaine for the management of intractable pain of the head and neck is effective in controlling pain in this patient group. With the catheter tip being located at the height of the C1 vertebral body, autonomic regulatory information may also be influenced by the infusion of bupivacaine. By combining direct sampling of cerebrospinal fluid (CSF), via a percutaneously placed catheter in the cisterna magna, with a noradrenaline and adrenaline isotope dilution method for examining sympathetic and adrenal medullary activity, we were able to quantify the release of brain neurotransmitters and examine efferent sympathetic nervous outflow in patients following intracisternal administration of bupivacaine. Despite severe pain, sympathetic and adrenal medullary activities were well within normal range (4.2 +/- 0.6 and 0.7 +/- 0.2 nmol min(-1), respectively, mean +/-S.E.M.). Intracisternal bupivacaine administration caused an almost instantaneous elevation in mean arterial blood pressure, increasing by 17 +/- 7 mmHg after 10 min (P < 0.01). Heart rate increased in parallel (17 +/- 5 beats min(-1)), and these changes coincided with an increase in sympathetic nervous activity, peaking with an approximately 50% increase over resting level 10 min after injection (P < 0.01). CSF levels of GABA were reduced following bupivacaine (P < 0.05). CSF catecholamines and serotonin, and EEG, remained unaffected. These results show that acutely administered bupivacaine in the cisterna magna of chronic pain sufferers leads to an activation of the sympathetic nervous system. The results suggest that the haemodynamic consequences occur as a result of interference with the neuronal circuitry in the brainstem. Although these effects are transient, they warrant caution at the induction of intracisternal local anaesthesia.

Does sympathetic nerve discharge affect the firing of myelinated cutaneous afferents in humans?

In clinical practise, the notion that some complex regional pain syndromes (CRPS) are associated with sympathetic facilitation of nociceptive transmission is widespread. However, physiological increases in cutaneous sympathetic nerve activity have not been found to influence the firing properties of cutaneous polymodal nociceptive (high-threshold mechano-heat sensitive) fibers in human subjects. Whether the same applies to low-threshold cutaneous mechanoreceptors is not known. Such an effect could be relevant for sympathetic facilitation of nociception, given that tactile afferents are implicated in the allodynia associated with CRPS. This issue was addressed by recording the responses of single cutaneous mechanoreceptors in the glabrous skin of the finger pads to constant mechanical stimuli, at rest and during physiological increases in cutaneous sympathetic activity produced by arousal stimuli. Unitary recordings were made from 17 rapidly adapting (15 FAI and 2 FAII) and 20 slowly adapting (9 SAI and 11 SAII) afferents located in the finger pads via tungsten microelectrodes inserted percutaneously into the median nerve at the wrist in nine subjects. A servomotor applied 1 s constant-displacement ramp-and-hold indentations to the receptor-bearing digit every 3 s. Displacement and compression force were recorded. Blood flow in the finger pad and sweating in the palm were measured contralaterally. Increases in cutaneous sympathetic outflow caused only modest changes in the spontaneous and compression-evoked firing of tactile afferents. These changes were usually (for 26/37 afferents) related to the associated decreases in skin blood flow. The latency from the start of the ramp stimulus to the onset of firing was inversely correlated to flow (i.e. unit response was delayed during vasoconstriction) for 11/31 units (7/15 FAI, 1/2 FAII, 2/9 SAI, 1/5 SAII), whereas no units showed a positive correlation. Compression-evoked firing rates were positively correlated to flow (i.e. vasoconstriction reduced firing rates) for 14/31 units (2/15 FAI, 1/2 FAII, 7/9 SAI, 4/5 SAII), whereas no units showed a negative correlation. 10/11 SAII afferents exhibited spontaneous background firing, which increased for 4 and decreased for 4 in response to arousal stimuli, presumably reflecting their sensitivity to changes in skin stretch associated with sympathetically mediated reductions in blood volume in the finger pad. Two afferents showed no change, but nor was there significant vasoconstriction in these recordings. Thus, arousal stimuli reduced rather than augmented tactile afferent firing. The close relation to blood flow for all types of afferents, and the different responses among SAII afferents, suggest that sympathetically mediated changes in afferent firing properties are indirect, i.e. secondary to changes in the mechanoreceptors' tissue environment rather than to a direct sympathetic effect on the endings.